NewsRx

Search our medical news database

Aradigm Corporation

Pharmaceutical firm announces $12.5M private placement financing

Published in Lab Business Week, January 30th, 2005

Aradigm Corporation (ARDM) announced that it had entered into a definitive agreement for a $12.5 million private placement of common stock and the concurrent issuance of warrants for the purchase of common stock.

Under the terms of the financing, Aradigm will sell approximately 8.3 million shares of common stock at $1.50 per share, representing a 16% discount to the closing price on the commitment date.

Gross net proceeds will be $11.75 million. Use of proceeds will include advancement of the company's R&D efforts, working capital and general operations. SG Cowen served as lead placement agent and Punk Ziegel served as co-agent for the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook